| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.5 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |